Zastosowanie gabapentyny w terapii napadow padaczkowych typu gromadnego u psow

• Autorzy: Wrzosek M , Zawadzki M. , Glinska K. , Nicpon J.

Warianty tytułu

EN

Usage of gabapentin for the therapy of cluster seizures in epileptic dogs

• Języki publikacji: PL

Abstrakty

EN

Epilepsy is a disease affecting 3% of the world population of dogs. Most of the patients respond relatively well to the antiepileptic drug therapy, which allows for the maintenance of a long interictal period. Life threatening situations in epilepsy are status epilepticus and cluster seizures. The authors present the usage of gabapentin in the treatment of cluster seizures of eight patients with epilepsy. Gabapentin at a daily dosage of 10 mg/kg is an effective drug in the treatment of cluster seizures in dogs, allowing for a prolongation of the interictal periods in these patients

Słowa kluczowe

PL

psy; napady padaczkowe typu gromadnego; zastosowanie; padaczka; napady padaczkowe; leczenie; choroby zwierzat; gabapentyna

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2006
• Tom: 62
• Numer: 06
• Opis fizyczny: s.669-673,rys.,bibliogr.

Twórcy

autor

Wrzosek M

• Akademia Rolnicza, pl.Grunwaldzki 47, 50-366 Wroclaw

autor

Zawadzki M.

autor

Glinska K.

autor

Nicpon J.

Bibliografia

• 1.Anhut H., Ashman P. J., Feuerstein T. J.: Long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in patients with refractory partial epilepsy. J. Epilepsy 1995, 8, 44-50.
• 2.Benetello P.: New antiepileptic drugs. Pharmacological Res. 1995, 314, 155- -162.
• 3.Berendt M., Gram L.: Epilepsy and seizure classification in 63 dogs: a reappraisal of veterinary epilepsy terminology. J. Vet. Intern. Med. 1999, 13, 14-20.
• 4.Berendt M.: Epilepsy. Internat. Vet. Info. Service, Ithaca NY 2002; B0230.0302.
• 5.Block F.: Gabapentin zur Schmerztherapie. Der Nervenarzt 2001, 72, 69-77.
• 6.Boothe D. M.: Anticonvulsant therapy in small animals. Vet. Clin. North. Am. Small Anim. Pract. Pub. Med. 1998, 28, 411-448.
• 7.Braund K. G.: Clinical Syndromes in Veterinary Neurology. Mosby St. Louis, Toronto 1994, 235.
• 8.Burgener I., Jaggy A.: Tremor. Handlexikon der tierärztlichen Praxis 1999, 204, 145-152.
• 9.Chrisman L. Ch.: Problems in Small Animal Neurology. Lea&Febiger, Philadelphia, London 1991, 121.
• 10.Gee N. S., Brown J. P.: The novel anticonvulsant drug, gabapentin (neurotin), binds to the alpha2delta subunit of a calcium channel. J. Biol. Chem. 1996, 271, 5768-5776.
• 11.Hill D. R., Suman-Chauhan N.: Localization of gabapentin to a novel site in rat brain: autoradiographic studies. Eur. J. Pharmacol. 1991, 31, 171-174.
• 12.Jaggy A., Bernardini M.: Idiopathic epilepsy in 125 dogs: a long-term study. Clinical and electroencephalographic findings. J. Small Animal Pract. 1998, 39, 23-29.
• 13.Jaggy A., Heynold Y.: Idiopathic epilepsy in the dog. Schweiz Arch. Tierheilk 1996, 138, 523-531.
• 14.Jehle T., Feuerstein T. J., Lagrèze W. A.: Der Efekt von Gabapentin und Gabapentin-Laktam auf das Überleben retinaler Gangliezellen. Situation nach akuter retinaler Ischämie im Tiermodell. Ophthal. 2001, 98, 237-241.
• 15.Jędrzejczak J., Zwoliñski P. (red.): Nowe leki przeciwpadaczkowe. Fundacja Epileptologii. Warszawa 2000.
• 16.Martinocić Ź., Ristanoviæ D.: Gabapentin in a treatment of migraine and epilepsy comorbid with mood and anxiety disorders. J. Headache and Pain 2001, 2, 83-87.
• 17.Mc Cleane G. J.: Gabapentin reduces chronic benign nociceptive pain: a double-blind placebo-controlled cross-over study. Pain Clin. 2000, 12, 81-85.
• 18.McLean M. J., Gidal B. E.: Gabapentin dosing in the treatment of epilepsy. Pub. Med. Clin. Ther. 2003, 25, 1382-1406.
• 19.Oliver J. E., Lorenz M. D., Korgenay J. N.: Handbook of Veterinary Neurology. Saunders W. B. Company 1997, 231.
• 20.On-Nin Wong J., Dou-Moo Tan T.: Gabapentin for the management of intractable postherpetic neuralgia: raport of 4 cases. Pain Clin. 2001, 13, 277-283.
• 21.Platt S. P., Haag M.: Canine status epilepticus: a retrospective study of 50 cases. J. Small Animal Pract. 2002, 43, 151-153.
• 22.Platt S. R., Adams V., Garosi L. S., Aramson C. J., Penderis J.: Gabapentin as adjunctive therapy for refractory idiopathic epilepsy in dogs. ESVN 16th Annual symposium, Praga 2003.
• 23.Podell M., Fenner W. R., Powers J. D.: Seizure classification in dogs from a nonreferal-based population. JAVMA 1995, 206, 1721-1728.
• 24.Podell M.: Antiepileptic drug therapy. Clin. Tech. Small Anim. Pract. 1998, 13, 185-192.
• 25.Prabhakar S., Bhatia R.: Management of agitation and convulsions in hepatic encephalopathy. Ind. J. Gastroenterol. 2003, 22, 54-58.
• 26.Saito M., Munana K. R., Sharp N. J. H., Olby N. J.: Risk factors for development of status epilepticus in dogs with idiopathic epilepsy and effects of status epilepticus on outcome and survival time: 32 cases (1990-1996). JAVMA 2001, 219, 618-623.
• 27.Tipold A.: Cerebrospinal fluid. Internat. Vet. Info. Service, Ithaca NY, Tierärztliche Hochschule Hannover, Germany 2002.
• 28.Trepanier L. A.: Use of bromide as an anticonvulsant for dogs with epilepsy. JAVMA 1995, 207, 163-166.
• 29.Vollmer K.-O., von Hodenberg A., Kölle E. K.: Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneimittelforschung 1986, 36, 830-839.
• 30.Wheeler S. J.: Manual of Small Animal Neurology. BSAVA, Gloucestershire 1995, 95-111.